Company Filing History:
2 out of 4,179 
1 out of 22 Years Active: 1989-2010
Title: The Innovative Contributions of Catherine M Smith
Introduction
Catherine M Smith is a notable inventor based in Carlsbad, CA (US). She has made significant contributions to the field of medical diagnostics and drug testing, holding a total of 3 patents. Her work has advanced the understanding and detection of various health conditions.
Latest Patents
One of her latest patents is titled "Methods of diagnosing tissue fibrosis." This invention provides a method for diagnosing the presence or severity of tissue fibrosis in an individual by detecting α2-macroglobulin (α2-MG), hyaluronic acid (HA), and tissue inhibitor of metalloproteinases-1 (TIMP-1) in a sample. The diagnosis is based on the presence or level of these biomarkers. Another significant patent is the "Fluorescence polymerization immunoassay for amphetamine/methamphetamine." This disclosure relates to a method for determining the presence of amphetamine and methamphetamine in biological fluids, such as urine, using a fluorescence polarization immunoassay procedure.
Career Highlights
Catherine has worked with prominent companies in the medical field, including Abbott Laboratories Corporation and Prometheus Laboratories Inc. Her experience in these organizations has contributed to her expertise in developing innovative diagnostic methods.
Collaborations
Catherine has collaborated with talented individuals such as Cynthia M Molina and Janis A Martinus. These partnerships have enhanced her research and development efforts in the field of medical diagnostics.
Conclusion
Catherine M Smith's contributions to innovation in medical diagnostics are noteworthy. Her patents reflect her commitment to advancing healthcare through technology and research. Her work continues to impact the medical community positively.